---
title: "bioAffinity Technologies surges 23% in midday trading on AvMEDICAL distribution deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296239174.md"
description: "BIAF jumped 23% after announcing a national distribution agreement with AvMEDICAL for its CyPath Lung lung-cancer risk test."
datetime: "2026-08-18T13:51:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296239174.md)
  - [en](https://longbridge.com/en/news/296239174.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296239174.md)
generator: "portal-rs"
---

# bioAffinity Technologies surges 23% in midday trading on AvMEDICAL distribution deal

bioAffinity Technologies(BIAF.US) 在盘中时段出现异动，截至发稿涨超**23%**，现报**0.4832 美元**。

消息面上，bioAffinity Technologies 宣布与 AvMEDICAL 签署全国性分销协议，通过 AvMEDICAL 的签约渠道将其 CyPath Lung 非侵入性肺癌风险评估测试引入美国联邦医疗市场，目标覆盖退伍军人事务部等政府采 购渠道，以简化采购流程并扩大该检测工具的覆盖面。

盘前时段该股已录得超 25% 的涨幅，多份盘前异动报道将其列为医疗健康板块活跃个股之一。此次异动主要由公司合作消息带动。

### Related Stocks

- [BIAF.US](https://longbridge.com/en/quote/BIAF.US.md)

## Related News & Research

- [bioAffinity Technologies Inc trading halted, news pending](https://longbridge.com/en/news/296671624.md)
- [bioAffinity Technologies effects 1-for-15 reverse stock split effective Aug. 24, 2026](https://longbridge.com/en/news/296486716.md)
- [bioAffinity signs AvMEDICAL distribution deal for CyPath Lung in federal healthcare market](https://longbridge.com/en/news/296224749.md)
- [bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules | BIAF Stock News](https://longbridge.com/en/news/295952568.md)
- [bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD | BIAF Stock News](https://longbridge.com/en/news/293471896.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**